Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
Clinical trial NCT04413123 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04413123
- Sponsor
- Bradley A. McGregor, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2026-12-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.